NCT01426386View on ClinicalTrials.gov

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

March 31, 2013

Conditions
Infertility
Interventions
DRUG

FE 999049

DRUG

Gonal - F

Trial Locations (8)

Unknown

UZ Brussel, Brussels

UZ Gent, Ghent

ICF CUBE, Prague

Rigshospitalet, Copenhagen

IU Dexeus, Barcelona

IVI Madrid, Madrid

IVI Sevilla, Seville

IVI Valencia, Valencia

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY